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Introduction

Recent studies suggest that there are 1.3 times as many microbial cells as human cells in
the body (Abbot, 2016). Another study claims that the combined genomes of this microbiota is
150 times that of the human genome (Zhuang & Shen, 2018). If you have ever had the feeling
that you are not alone in an empty room you are most certainly correct. Your body is teeming
with millions of organisms living in mutualistic symbiosis with you and surrounding microbes,
but at times, this seemingly harmonious relationship can be disturbed, resulting in serious
physical and psychological changes to the human body.
This thesis will explore many of the proven and possible ramifications of the oral and gut
microbiota’s metabolic systems. Primarily, literature regarding the current understanding of the
human microbiome will be explored. This includes studies that review common human
microbiome compositions and various contributors to differing microbiomes such as
geographical location and diet. Next, there will be a review of specific methods utilized by
microbes to influence the human body. Benefits of homeostasis of the human microbiome will
be described. Contrastingly, there is abundant literature that supports the notion that disorders of
the GI tract and neurodegenerative disorders of the brain actually stem from microbiome
dysbiosis defined as any deviation from homeostatic concentrations of bacteria. The possible use
of probiotics, prebiotics, and fecal transplants will be considered as treatment for microbiome
dysbiosis and related disorders. Finally, I will turn to a review of neurodegenerative disorders,
with a focus on Alzheimer’s (AD) and its biological processes. Then I will expand on the
dysbiotic microbial influence on the pathogenesis of AD. The conclusion of this paper will
consist of possible holistic preventative measures for microbial dysbiosis and AD.
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The Microbiome

Introduction to the microbiome
In the past few years, scientists have begun to uncover the evolution and symbiosis of
humans and microbes. Microbes include viral, bacterial, fungal, and archaeal organisms. The
human microbiota is defined as the collection of roughly three pounds of microbial organisms
found on and in the human body. The microbiome is the entirety of that microbial genomic code.
The microbial proteome, specifically, is the microbial genes that are actually expressed and
translated into proteins (Reid & Shannon, 2013).
What is considered a “normal” microbiome?
Only recently, scientists have begun to pay mind to the possible impact these microbes
may have on animal health and disease. The study of metagenomics is made possible by novel
sequencing techniques including high throughput sequencing such as Illumina. These novel
techniques take a fraction of the time and effort to sequence large quantities of genetic data. This
process usually involves a total extraction of genetic material from a sample (such as fecal or
tooth plaque) followed by polymerase chain reaction (PCR) amplification of the 16S ribosomal
RNA (or 16S rRNA) variable region. These amplified genes can then be sequenced through
fluorescently labeled nucleotides that are analyzed and recorded using general electrophoresis
and chromatography techniques. These data are then compared to other genomic sequences in
rapidly growing bioinformatics databases (Alonso & Guarer, 2013).
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The Human Microbiome Project was founded to orient future research by establishing a
baseline or normal relative abundance of bacterial populations in the human microbiome. There
are various distinct microbiomes in the human body that consist of characteristic bacterial
communities such as the oral, gut, stomach, skin, and vaginal microbiome. Each microbial
community can be further characterized by belonging to a different enterotype. Microbial
enterotype is a classification of humans based on varying prominent bacterial concentrations. For
instance, the three distinct enterotypes are based on a variation in concentration of one of three
genera: Bacteroides, Provetella, and Ruminoccocus. Diagrams of these three enterotypes are
shown in Figure 1 (Keim, 2011). This research is still in preliminary stages and far more research
has to be done to provide supporting evidence of this form of gut enterotype classification.

Figure 1

Figure 2

This figure shows the three most prevalent human
gut microbiome enterotypes

Overall prevalence of various microbes
in the human gut microbiome.
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Nevertheless, a vast majority (more than 95%) of the gut microbes consist of Firmicutes and
Bacteroides (Fig 2); (Alonso & Guarer, 2013). These two bacterial phyla are associated with
digestion of carbohydrates, storing energy, and maintaining immune function.
Normal development of the human gut microbiome during one’s life
The human microbiome varies within an individual’s lifetime and is built in successive
steps. In an infant, the gut is colonized by facultative anaerobes including Streptococcus,
Enterobacteriaceae, and Staphylococcus. These microbes consume oxygen to create an
anaerobic environment for strict anaerobes including Clostridium, Bacteroides and
Bifidobacteria. After the first two years of life, the gut microbiome begins to increase in
Firmicutes and resemble that of an adult microbiome. After a diverse adult microbiome is
established, it is relatively stable and unchanging unless disrupted by a dramatic event (such as
antibiotic regimens) (Oriach et al., 2016).

Gut Human Microbe Symbiosis and Homeostasis

Microbe host interaction
The gut microbiome interacts with the human host on a chemical signaling level and physical
digestive level through metabolic intermediaries including cytokines, neurotransmitters, and
short chain fatty acids (SCFA). The immune system also responds to microbial associated
molecular patterns (MAMPs), which are molecules that are part of microbes including
lipopolysaccharides (LPS) and peptidoglycan (PGS). The effect of these metabolites on the host
can vary depending on the state of the host and the concentration of the metabolites (Minter et
al., 2016).
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Three principle microbial communication forms
1. Blood
Bacteria can communicate with the brain via blood circulation. This method is made
possible by the breakdown of epithelial cell tight junctions in the gut, gums, and in the blood
brain barrier. These tight junctions usually prevent the passage of water, bacteria and other
metabolites across membranes. When these tight junctions are broken down, bacteria and
bacterial metabolites (such as SCFA or cytokines) can more easily gain access to the blood and
enter the brain. It is also important to note that because the mouth is closer to the brain, it is
easier for bacteria to travel through the perforated gum lining to the brain relative to a leaky gut
to the brain. Increased permeability of membranes in the body facilitate the influence of gut
bacteria’s communication to the brain leading to an inflammatory response of the central nervous
system (CNS), which can lead to neural degeneration (Perez-Parado et al., 2017).
2. Vagus nerve and the gut microbiome
The vagus nerve stretches from the medulla oblongata in the brain stem to the
gastrointestinal (GI) tract as an important modulator of the “brain-gut” axis. The nerve serves as
a bidirectional chemical communication highway between the brain and the bacteria of the gut.
Neurotransmitters produced by bacteria are able to access the brain using this “highway”.
3. Trigeminal and olfactory nerve and the oral microbiome
The oral nasal cavity is innervated by the trigeminal nerve and the olfactory nerve that
serve as direct highways for oral bacteria and associated metabolites to the brain. The bacteria
start in the oral and nasal cavities and move through the olfactory nerve, the olfactory bulb, the
perennial cortex (associated with facial recognition), and the hippocampus (associated with short
6

term memory). The Olfactory Hypothesis dictates that pathogens can enter the brain though the
olfactory tract and increase production of amyloid plaques as well as neurofibrillary tangles.
Staphylococcus aureus can travel to the olfactory bulb unimpeded regardless of immune
mechanisms (Shoemark & Allen, 2014).
Microbial mechanisms in the human body
Gut microbes utilize these communication forms to perform a series of important jobs in the
human body summarized in the following text: They facilitate immune function and promote the
development of the immune system. By exposing the body to a variety of non-threatening
microbes, the immune system tends not to overact to foreign bodies resulting in lower risk of
autoimmune disease. A stable microbial community prevents the domination of the microbiota
by another pathogenic bacterial strain (Sherwood, 2015). Microbes also aid in food digestion.
For example obligate anaerobic gut microbes are responsible for metabolizing food substrate into
energy, SCFA and other nutrients for humans; the human genome codes for fewer than 20
carbohydrate digestive enzymes. However, one strain of bacteria found in the human gut,
Bacteroides thetaiotamicron, contains a genome encoding for 260 different carbohydrate
digestive enzymes. Proof of the integral role of the microbiome on digestion can be seen in
problems that arise in initial attempts to feed malnourished people. Starving people experience a
depletion in gut microbial populations, as they provide no food or substrate for the microbes. If
that starving person is given food, they will not gain substantial weight, nutrients or energy from
that food until their gut microbiome has been reestablished (Reid & Greene, 2013). Recently,
with the discovery of the influence of microbes on the brain, this topic is being thoroughly
researched. Some SCFA are also integral in healthy acidification and regulation of the pH of the
gut lumen to inhibit pathogenic invasion. Firmicutes produce the SCFA butyrate, which is
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important in tissue maintenance because it provides nutrition and energy to the tissue. Butyrate is
known to prevent leaky gut syndrome, which is caused by the breakdown of the epithelial cells
in the cell wall that permits toxins, undigested food, and bacteria to leak into the bloodstream.
Finally, SCFA treatment has been shown to ameliorate Irritable bowel disease (IBD) and colon
cancer by preventing buildup of branched chain fatty acids (Alonso & Guarer, 2013).

Gut Microbiome Dysbiosis

What is dysbiosis?
Even though there is variance of microbial concentrations in the gut between individuals,
the relative abundance of these bacterial species is generally constant throughout an individual’s
life. An imbalance of the microbes in one’s gut can lead to a state of dysbiosis, which can
dramatically increase the risk for a number of disorders. Dysbiosis can lead to a single organism
dominating the microbiome or the drop in concentration of a single species whose functional role
was integral to the maintenance of homeostasis in the human body. This change in bacterial
relative abundance as well as the change in the bacterial metabolites present in the body can
affect human metabolism on a physical and chemical level.
What causes dysbiosis?
Various environmental stressors can induce change in the relative abundance of microbes
in the microbiome resulting in dysbiosis. These stressors include strong antibiotic regimens,
access to clean water, general cleanliness, cesarean sections, reduced breastfeeding, access to
animals or livestock, and dietary changes. Gut microbiome dysbiosis is most often caused by
antibiotic treatment (especially broad spectrum treatments) that wipe out, indiscriminately, the
8

diverse population of the gut microbiota. These drugs are usually administered with intent to kill
a single pathogenic bacteria, but result in the genocide of both “good” and “bad” bacterial
species. This loss of diversity can accentuate dysbiosis instead of ameliorating it.

Alzheimer’s Disease

Introduction to AD
Dementia is a set of symptoms such as poor memory and inhibited learning/cognitive
functions that results from a physical degenerative cause. AD is one of the most common causes
of dementia. AD induces neural death in the brain especially in the cortex and hippocampus
where higher cognitive functions occur and long term memories are stored. Symptoms of AD are
progressive. Initially AD may not be detectable. Short term memory loss is the first detectable
indicator of AD, followed by loss of motor skills and language, long-term memory loss,
disorientation, and death (Shoemark & Allen, 2014).
Mechanisms and pathogenesis of AD
One of the major causes of AD is the formation of beta amyloid plaques that build up
around neural cells in CNS. Amyloid precursor proteins (APP) are imbedded in the neural
membrane and are believed to assist in neural growth and repair. In a normal brain, alpha and
gamma secretase enzymes cleave APP’s and the products are solubilized and recycled by
cerebral fluid. However, in AD patients, beta and gamma secretase enzymes are used to cleave
the APP’s instead, which results in insoluble monomers called amyloid beta peptides. The
buildup of these monomers form beta amyloid plaques (Cheignon et at., 2018). Amyloid protein
denaturation and buildup spreads from neuron to neuron relatively quickly. This cascading
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spread of insoluble misfolded proteins characteristic to AD has been labeled as prion-like
(Pistollato et al., 2016). These plaques cause many pathogenic effects such as disrupting the
transmission of neural signals if they form in the synaptic cleft of two neurons. The plaque can
also stimulate immune responses that catalyze cascading inflammation. Often, if an immune
response is stimulated, CNS glial cells such as microglia (macrophages) and astrocytes (that help
form a blood brain barrier (BBB)) can become overactive. Microglia can be activated when their
toll-like receptors (TLR) recognize MAMPS. When there is a dysbiotic abundance of bacteria
exhibiting a specific MAMP, microglia become overactive and they phagocytize, not only
bacteria/foreign particulates, but also components important to effective functioning of the
nervous system, such as neural synaptic terminals as well as myelin sheaths (Minter et al., 2016).
Myelin sheaths are protein coats that wrap around the axon of neural cells to insulate and
increase the rate signal transmission by inducing salutatory signal transmission. Without myelin
sheaths, signal transmission is inhibited dramatically (Pistollato et al., 2016). In AD sites of
inflammation, astrocytes are over-stimulated and release proinflammatory cytokines including:
tumor necrosis factor alfa (TNFα), interleukin-1 beta (IL1β), and apolipoprotien E (ApoE). The
malfunction of these factors are involved in amyloid β peptides (Aβ) fibrillation and cerebral
oxidation (Shoemark & Allen, 2014, & Vogt et al., 2017) which contribute to pathogenesis of
AD.
Correlative evidence shows that buildup of beta amyloid plaque leads to the second major
cause of AD: the buildup of protein Tau tangles within neural cells. Tau proteins are located on
microtubules within the cytoskeletal matrix of the axon of a neural cell. Under normal conditions
Tau proteins help maintain the stability of microtubules. Microtubules are used as cellular
‘highways’ to transport nutrients into the cell body and waste out of the cell body. However, in
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AD patients, buildup of amyloid beta plaques stimulate a kinase enzyme (p38 Mitogen-activated
protein kinases or MAPK) that phosphorylates Tau proteins, causing the Tau proteins to fall off
the microtubule and accumulate in clumps of neurofibrillary tangles. As Tau proteins fall, the
integrity of the microtubule degrades and they are broken down. This results in breakdown of the
neural highway, a halt in transmission of nutrients to the cell body, and eventual neural death.
(Cheignon, et at., 2018)
Oxidative stress is also a major contributor to the pathogenesis of Alzheimer’s disease.
Chemical reactions occurring can produce volatile oxygen species that can react with, and cause
degradation of surrounding tissues. Specifically, incomplete reduction of oxygen in the electron
transport chain can produce oxygen radicals that are known to break down lipids, proteins, and
nucleic acids. Oxygen radical species include superoxide, peroxide, and hydroxide. Carbonylated
proteins are known to be indicators of protein oxidation. A study performed by Hensley and his
laboratory found a buildup of carbonylated proteins in the hippocampus and cortex. These
regions are the main sites of Aβ plaque buildup and tissue degradation characteristic of AD
(Hensley et al., 1995). Also, lipid peroxidation is hypothesized to contribute to asymmetry and
permeability in phospholipid bilayers of synaptic regions of neuronal membranes. Finally, the
lipid peroxidation product: 4-hydroxy-2-nonenal (4-HNE), is known to cause oxidation and
degradation of Tau proteins (Liu et al., 2005).
Alzheimer’s classifications
There are two principle classifications of AD. The first major form of AD is familial or
early onset Alzheimer’s which is caused mainly by genetic factors. Familial AD is dictated by
dominant gene mutations in Presenilin (PS), which is one of the four core proteins that compose
the gamma secretase complex (Shoemark & Allen, 2014). Malfunction of the gamma secretase
11

enzyme due to a PS mutation can lead to increase in production and aggregation amyloid beta
plaque. An experiment shows that murine test subjects with PS knockout have a significant
buildup of Aβ plaque as well as cortical atrophy. After nine months of PS inactivation there was
24% cortical neuron loss and 35% cortical volume loss. They also noted memory loss and loss in
synaptic plasticity due to N-methyl-D-aspartate (NMDA) receptor inhibition. NMDA receptor
proteins located on the synaptic cleft of neurons bind to glutamate to increase calcium influx and
signal transduction in neurons. Finally, they found PS inhibited mice had a decrease in cyclic
adenosine monophosphate (cAMP) response element activity. This cAMP molecule is used in
signal propagation and signal cascades (Shen and Kelleher III, 2007). Additionally, trisomy of
the 21st chromosome can increase the risk of early onset AD because the APP gene is located on
this chromosome. With a higher production of APP these people have a higher chance of
amyloid beta plaque buildup. (Shen & Kelleher, 2007).
The second and most common form of Alzheimer’s is sporadic or late onset. This form of
AD is caused by mainly environmental factors and a few hereditary factors. With respect to the
latter genetic links, the e4 allele of apolipoprotein E can increase risk of late onset AD. Normal
allelic expression (not type e4) of apolipoprotein E results in the breakdown of amyloid beta.
However, the e4 allelic version of this protein does break down amyloid beta tissue as well
(Cheignon, et at., 2018). Environmental risk factors for CNS aggravation and AD pathogenesis
include increased age (typically, people above the age of 60), diet high in fats and sugar and low
in fiber, microbiome composition (as will be the focus in this paper) as well as other factors.
Because sporadic AD is more common and is more likely to be affected by the environment,
namely gut and oral microbial communities, this form will be the focus of this study and
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hereafter. Any discussion of AD is referring to the sporadic form unless otherwise noted
(Cheignon, et at., 2018).

Effect of Oral Microbiome on AD

Bacteria found in the oral microbiome have been known to contribute to AD
pathogenesis. The bacteria of the oral microbiome are located closer to the brain than the gut and
therefore have a shorter distance to travel to affect the brain. These bacteria and their metabolites
can pass from frequently aggravated gums into the blood stream and through the blood brain
barrier. Various types of oral bacteria are correlated with ageing such as anaerobic bacteria.
Some anaerobic strains of bacteria produce tumor necrosis factor alpha (TNFα) proinflammatory
cytokine that has been known to contribute to the progression of AD. A major limitation of the
study of the oral microbiota is that many strains of bacteria in the mouth are difficult to culture in
laboratory or entirely uncultivable. This is mainly due two main factors: The first being there are
many unknown obligatory symbiotic relationships between specific strains of bacteria that would
have to be accounted for to grow that strain in culture. Metabolites such as growth factors (GF)
provided by one species of bacteria may permit a second species to grow (Strandwitz et al.,
2019). The second factor is that it is difficult to grow anaerobic bacteria in culture (Shoemark &
Allen, 2014).
Dominy et al. (2019) found that AD murine models had a much higher concentration of
Porphyromas gingivalis, an anaerobic bacterium known to cause periodontitis. In AD mice there
were increased concentrations of P.gingivalis, which produces neurotoxic, proteolytic gingipian
enzymes, which are needed for the survival of the bacteria and pathogenic effect on the host.
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There are three types of gingipains produced by P. gingivalis including: lysine-gingipain (Kgp),
arginine-gingipain A (RgpA), and arginine-gingipain B (RgpB). High concentrations of
gingipains Kgp and RgpB directly correlated to build up of Tau tangles and increase in
concentration of ubiquitin. Ubiquitin is an enzyme that is used in the production of APP’s and
correlates to a higher concentration of Aβ plaque deposition. Figure 3 superimposes a stain of
cerebral RgpB buildup, a stain of Tau tangles, and a stain of Aβ plaque. It is clear that the protein
aggregations directly correlate with the gingipain depositions. Figure 4 shows an increase in
concentration of RgpB, Kgp, Tao, and ubiquitin load in AD patients compared to controls.

Figure 3

Figure 4

Cerebral RgpB build up causes Aβ
plaque aggregation

C & D: show gingipain build up increased in
Alzheimer mice
E & F: show tau load increase in AD mice
G & H: show ubiquitin build up (indicating Aβ
plaque aggregation)
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These results led to a follow up experiment where a short peptide narrow spectrum
antibiotic called COR388 was designed to block Kgp proteolytic activity. Inhibition of Kgp led
to a dramatic decrease in P. gingivalis in the oral microbiota and a correlative decrease in Aβ
protein. The Diagram in Figure 5 shows a decrease of bacteria and Aβ protein build up with an
increase in COR388 antibiotic (Dominy et al., 2019).

Figure 5
J: Higher concentrations of COR388 antibiotic lead to lower concentrations of P.gingivalis
K: Higher concentrations of COR388 antibiotic lead to lower concentrations of Aβ protein buildup
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Effect of the Gut and Stomach Microbiome on AD

The human gut microbiota alone is composed of over 104 organisms including over 2000
bacterial species. Metabolic activities of gut microbes release exudates that are used as signaling
molecules by the host body and can influence various aspects of homeostasis (Pistollato et al.,
2016).
Some scholars argue that amyloid proteins produced by bacteria are analogous to those
found in the brain that lead to Aβ plaque buildup. Amyloid proteins are used by bacteria to form
biofilms (often with cytotoxic effect to the host) and facilitate bacterial adhesion, aggregation,
colonization, and tissue invasion (Pistollato et al., 2016). Additionally, a study performed by Asti
and Gioglio, 2014 found that buildup of amyloid A proteins in senile plaques of AD patients lead
to subsequent upregulation of various cytokines or signaling molecules including interleukins
(IL) and tumor necrosis factors (TNF), specifically: IL-6, TNF- alpha, IL-12, p19 and IL-10. If
over expressed, these cytokines stimulate inflammation. It is likely that they play a role in AD
pathogenesis (Asti & Gioglio, 2014). Aggregate amyloid proteins have been known to cause
reactive oxygen species accumulation as well as microglial inactivation. Amyloid aggregation
can activate nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling,
which results in a signaling cascade that impairs microglia phagocytosis of Aβ plaque.
Escherichia coli, Salmonella enterica, Salmonella typhimurium, Bacillus subtilis,
Mycobacterium tuberculosis, and Staphylococcus aureu are all known to produce amyloid
protein. In fact, abnormally high concentrations of E.coli have been correlated to the formation
and aggregation of Aβ fibrils and AD pathogenesis (Pistollato et al., 2016).
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Notably, the presence of LPS metabolites in normal quantities are used to control
homeostatic mechanisms, inflammation, permeability, and sepsis. However, a buildup of LPS
can result in activation of signaling pathways that cause neurodegeneration and inflammation in
the brain. In vitro studies show that a large concentration of LPS added to bacterial amyloid
proteins can result in protein polymerization/aggregation that could contribute to oxidative stress
of the brain. A buildup of LPS metabolites can also exacerbate gut leakiness and increase levels
of proinflammatory cytokines such as interleukin (IL)17A and IL-22. These two cytokines have
been associated with AD in past studies.
Studies show that both Lactobacillus and Bifidobacterium break down glutamate to
produce gamma-Aminobutyric acid (GABA), an inhibitory neurotransmitter. Abnormal
concentrations of these two types of bacteria could lead to abnormal concentrations of GABA
which can lead to poor mental health including AD and anxiety. Other SCFA present in
disproportional amounts can be a threat and they are integral in glycolysis and energy derivation
in the brain as well as immune response and other homeostatic mechanisms (Pistollato et al.,
2016).

A study was performed by Minter et al. 2016 in Stanford University on the effect of gut
microbial communities on microglial activity and AD pathogenesis. This study focused on male
murine models that were subjected to rounds of antibiotic treatment (ABX mice) compared to a
control group (vehicle). When subject to rounds of antibiotic treatment their gut microbial
population changed in relative species diversity but not overall quantity of microorganisms.
Change in dominant bacterial strains changed the overall gene expression, metabolite production,
cytokine and chemokine production. In the host for example, CCL11 is a bacterial metabolite
that can function as a cytokine to cross the blood brain barrier and lead to microglial activation
17

and phagocytosis. CCL11 was found to be elevated in ABX mice. In conclusion, they found that
ABX mice actually had altered microglial morphology and microglia that were generally more
efficient. In the same study study, the ABX mice with increased microglial activity had a
decrease in Aβ plaque and tested better for long term memory (Minter et al., 2016). It should be
noted that an increase of microglial activity and efficiency could be a preventative measure for
AD because this phagocytic enzyme can consume Aβ plaque. However, an overstimulation of
microglia can be a causative agent of AD and memory loss as microglia consume nonpathogenic
particulates such as neural synapses (neurite degeneration) or myelin sheaths. Finally, a major
limitation of this study is that these scientists confirmed a correlation between a change in the gut
microbiome composition, microglial activity, and AD pathogenesis but they were not able to
identify which particular species of bacteria or bacterial gene was causing the inhibition of
microglial activity. In a later interview when Sangram S. Sisodia, one of the scientists working
on these experiments, was asked about a possible next step to better understand how the gut
microbiome effects microglial activity and protein buildup, he said a series of bacterial gene
knockout experiments could be performed to determine which gene was contributing to
microglial inhibition (Minter et al., 2016).

A study was performed by Vogt et al. 2017 on fecal samples of 50 human patients, 25 of
whom had AD. They found an overall decrease in biodiversity, an increase in Bacteroides and a
decrease in Fimicutes and Bifidobacterium. Biodiversity was measured in operational taxanomic
units (OTU) or bacterial types. In AD patients there was an increase in 14/83 OTU and the rest
decreased. This led to a significant overall loss in biodiversity and richness in the gut
microbiomes of AD patients. There was a defined increase Bacteroides and Blautia among other
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bacteria. Additionally, there was a significant loss of Firmicutes and Bifidobacterium (Vogt et
al., 2017).
This combination of change in bacterial relative abundance is a microbial recipe for
disaster. The Bacteroides Gram-negative cell wall has an outer LPS (also known as lipoprotein
A) layer that stimulates the immune system to release of proinflammatory cytokines. Therefore,
an increase in this bacteria results in systemic inflammation. Firmicutes exudate butyrate is
important in nourishment and maintenance of the BBB. Bifidobacterium has anti-inflammatory
effects and decreases membrane permeability. Studies show that an increase in Bifidobacterium
in mice results in decreased bacterial translocation through permeable membranes.
Bifidobacterium is found in many probiotics. In summary, if Bacteroides has increased access to
the CNS through the blood stream after a breakdown of the gut membrane and BBB (facilitated
by the decrease of Bifidobacterium and Firmicutes), Bacteroides LPS has a more direct access to
the brain and can cause cerebral inflammation (Vogt et al., 2017).
Brain tissue surrounding plaque buildup of AD patients was found to have abnormal
presence of LPS. Studies have shown that in vitro cultures, LPS stimulates fibrillogenesis in
amyloid beta peptide. Additionally, in vivo studies in mice show that injections of LPS increased
amyloid beta plaque and Tau aggregation. Postmortem studies show that human AD brain tissue
contained Gram-negative E. coli and LPS aggregation in the brain along with AD plaque
deposition. An increase in permeability allows Gram-negative bacteria and LPS more direct
access to the brain (Vogt et al., 2017).
This article also mentions that type 2 diabetes is known to be comorbid with AD. Both of
these disorders are characterized by a decrease in the richness of Firmicutes and an increase in
the richness of Bacteroides and therefore display similar states of gut dysbiosis. It is also worth
19

noting that insulin resistance, a hallmark of diabetes, which causes a decrease of glucose cerebral
metabolism is also correlated to an increase in amyloid plaque deposition.

Another study performed by Zhuang & Shen (2018) showed a clear difference in the
composition of gut microbiomes of patients with AD compared to controls. They noted that AD
patients had a high concentration of Ruminococcus bacteria in comparison to controls. High
concentrations of Ruminococcus generally correlate to low concentrations of N-acetyl aspartate,
which is an indicator of neuronal health. This study also mentions the possible contributions of
Helicobacter pylori, a stomach bacterium, to an increase in Aβ plaque deposition in AD patients
(Zhuang & Shen, 2018).

Environmental Risk Factors for Alzheimer’s Disease Pathogenesis

A major limitation in this thesis investigation is the fact that there are multiple
contributing independent variables that play a role in the pathogenesis of sporadic AD.
Specifically, the evolving human diet and age are two factors that play integral roles in AD
prevalence and development.
Aging: Increase in AD prevalence as human lifespan increases
As people age, their risk of developing AD is greatly increased. Concurrently, as people
age, there is a notable change in many physiological factors and microbial concentrations. There
have been dramatic increases in life expectancy over the course of human history, particularly in
the last hundred years. Even more recently, in 2010 global life expectancy has reached sixty
eight years, which indicates a twenty-one year increase just since 1995. This steep increase in
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life expectancy is attributed to controlling the spread of communicable diseases as well as a
developed understanding of medicine and its application (Wayne, 2019). Due to the fact that AD
diagnosis and pathogenesis occurs later in life, AD appears to be a recent health issue among
humans because of a relatively recent increase of the average human lifespan. Based on current
ascending trends, the number of people with AD is projected to more than double by 2050 from
5.8 million to 13.8 million (Kondro, 2010). Many scholars have questioned the change in
prevalence of AD over time and some attribute it to a change in the composition of the
microbiome of the human population. It is difficult to separate the aging process from AD
development to determine the precise causal agent for AD. The main factors associated with both
aging and AD are increased microbial dysbiosis, increased total bacterial load, a weakening
immune system, and a decrease in tissue integrity of the BBB (Shoemark & Allen, 2014).
Aging is indirectly correlated to the immune system’s ability to function. Microglia, for
instance become less effective in clearing plaque and waste buildup as age increases. This makes
the body more susceptible to microbial dysbiosis as there are fewer checks and balances in the
body against a rapid increase in relative abundance of pathogenic bacteria (Minter et al., 2016).
In the mouth, there is also a decrease in lysozyme containing saliva production, which permits
the growth of bacteria (Shoemark & Allen, 2014).
In the gut microbiome of the elderly, there is a marked change in microbial
concentrations including an increase in Gram-negative Bacteroidetes and decrease in Firmicutes
and Bifidobacteria (Pistollato et al., 2016).
Also, in the oral microbiome, AD patients have a noteworthy increase in the
concentration of anaerobic bacterial species due to an increase in pocket depth and the use of
dental prostheses. This overall increase in anaerobic bacteria and overall bacterial load results in
21

a stimulation of inflammatory pathways by evoking the increased release of TNFα and IL1β.
These are immune system triggers released by glial cells upon pathogenic bacterial encounters.
Increased concentrations of TNFα can also contribute to breakdown of the BBB (Shoemark &
Allen, 2014).
To reiterate, a major complicating aspect of my research paper is the fact that aging and
microbial compositional shifts occur concurrently. Therefore, it is difficult to know if the
bacterial change is a causal factor of AD or simply occurs independently at the same time.
Human bacterial coevolution
The contributions of H. pylori in the stomach microbiome to AD pathogenesis is
currently being investigated. Scientists have hypothesized that H. pylori may contribute to Aβ
plaque production as well as Tau phosphorylation, resulting in a progression of AD (Zhuang &
Shen, 2018). However, H. pylori has only recently been incorporated as a part of the human
stomach microbiome during the transition from a hunter-gatherer lifestyle to a more sedentary
agricultural lifestyle during the Neolithic age (generally within the past 10,000 years, with
independent origins of agriculture worldwide). For instance, in central Africa nearly 4,500 years
ago, H. pylori strains were introduced to rainforest hunter-gatherer communities by agricultural
communities (Patin et al., 2013). Humans have lived as hunter gatherers/foragers for the vast
majority of human evolutionary history of nearly two million years (e.g., genus Homo) with a
relatively diverse, “broad spectrum” dietary regime that stands in contrast to today’s “Western”
diet (Warinner, 2015). While it is difficult to determine the prevalence of AD that far in the past
of human evolutionary history (though there are tantalizing hints that the selection for genes tied
to brain metabolic development in the origin of anatomically modern H. sapiens species 50-200
thousand years ago may be associated with AD), it is still interesting to see the way in which the
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human microbiome has developed over time, with implications on susceptibility to AD (Rogers,
2015).
Diet: Increase of AD prevalence as human diet changes
Diet has been linked to an alarmingly rapid rate of decrease in microbial diversity.
(Davenport et al., 2017). There are two principle diet types: Western and Non-Western-style
diets, that result in two very distinct gut microbiomes (Oriach et al., 2016). It should be taken
into account that these two diet types are not specific to geographical location but rather to diet
composition. Foods in Non-Western diets could include things like sweet potato, wheat, barley,
lentils, berries, vegetables (Lipski, 2010). The Non-Western diet is considered a more traditional
and natural diet that resembles the hunter gatherer diet. The Non-Western diet is generally
composed of low fat, low sugar, and high fiber foods. Alternatively, foods included in the
Western diet include things like cheese, butter, high-fructose corn syrup, and foods with
increased sodium concentrations (Cordain, 2005). The Western diet focuses more on processed
contemporary foods and is composed of high fat, high sugar, high meat, and low fiber foods
(Oriach et al., 2016). The westernization of diets has come about with a transition from a hunter
gatherer to sedentary lifestyle (Warinner, 2015).
1. The Western-style diet
Experiments have shown that the altered gut microbiota due to the Western diet causes
increased inflammation and induced dementia (Oriach et al., 2016). On the other hand, there are
some strains of bacteria ingested that are labeled “psychobiotics” that correlate to improved
mental health. However, very little is known about the specific mechanisms of the microbial
metabolites and their interactions with the brain (Oriach et al., 2016, & Serkov et al., 2018). In
vivo murine studies showed that high fat, high sugar diets (emulating Western diet ) resulted in a
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dysbiotic change in the microbiome and a consequential decrease in memory (memory was
tested using the Morris water maze test where the mouse must find a platform within a circular
pool of water that helps it escape the pool) (Oriach et al., 2016). The results of this study are
summarized in Table 1 that follows. (Note that good performance on the Morris Mouse Maze
test means good spatial short term memory)
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Table 1
Morris Mouse Maze Studies on Diet and Behavior

Diet

Intervention Length

Microbial Changes

Behavioral changes

High fat

8 weeks

↑[Firmicutes &

↑anxiety

Ruminococcaceae]

↓memory (Morris

↓ [bacterial diversity]
High sucrose diet

2-5 weeks

water maze test)

↑[Clostridiales,

↓memory (morris

Lactobacillus, &

water maze test)

Lactococcus]

↓ [Baceriodites]
Meat containing diet

3 months

↑[bacterial diversity]

↑long term memory
↓anxiety like
behavior

Western style diet

21 days`

↑[Firmicutes]

↓SCFA

↑[Spirochaetes]

Another study dictated that high fat diets specifically resulted in a decrease in
Bifidobacterium. When Bifidobacterium is present in moderate quantities, it has antiinflammatory effects and decreases membrane permeability (Serkov et al., 2018). Yet another

25

study showed that Western diets resulted in a disproportionally large increase in the
concentration of Firmicutes to Bacteriodetes ratio. Firmimcutes and Bacteroidetes are two of the
most prevalent bacteria already present in the human gut microbiome. If Firmicutes/
Baceriodetes ratio increases, there is a reduction of the total diversity of the microbiome which
leads to dysbiosis as well as increased membrane permeability. Researchers speculate that the
rise in concentration of Bacteriodetes occurs because Bacteriodetes metabolize the increased
amounts of amino acids derived from meats found in western diets (Pistollato et al., 2016).
2. The Non-Western diet
The Non-Western diet results in an increase in Proteobacteria (Davenport et al., 2017) and
Provecella (Pistollato et al., 2016). Provecella break down plant material found in higher
quantities in the Non-Western diet. Non-Western diets rich in fiber encourage the growth of a
diversity of “good microbes” such as Bifidoboacterium in the gut. Fiber is considered a major
prebiotic or substrate that encourages bacterial growth that is beneficial to the host. Murine
models show that mice with higher fiber diets had improved overall mental health (Oriach et al.,
2016).

Holistic Preventative Measures for AD

A common theme in my research paper is that a single metabolite or bacterial strain
present in dysbiotic proportions can contribute to neurodegeneration and other serious
impairments. This leads to the conclusion that is counterintuitive to the traditional clinical
approach of searching for a single pathogenic culprit for a disorder. Instead of targeting the
presence of a specific “bad bacterium” for a disease state, the problem seems to be the absence of
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“good bacterium”. This absence and decrease in interspecies bacterial competition provides the
ecological space for the overgrowth of other types of bacteria. This results in a disproportionate
concentration of bacterial metabolic exudates that likely contribute to the pathogenesis of AD.
Therefore, some of the best holistic preventative measures that can be taken to lower risk
for AD are those that establish and maintain a stable and diverse gut and oral microbiome. The
establishment of a healthy diverse gut microbiome in the first two years of life is important in a
generally more resilient immune system and improved health overall (Reid and Greene, 2013).
Diet
Homeostatic microbial concentrations can be enforced by dietary intake that resembles a
more traditional, Non-Western diet. Clinical data shows that patients are less likely to develop
AD if they have a higher intake of whole grains, fiber, fruit, vegetables, legumes, fish, and low
fat dairy. Many of these foods act as prebiotics. A prebiotic is a substance that encourages the
growth of certain beneficial strains of bacteria. Foods that should be avoided include those that
are high in fat and refined sugar. Patients who follow this type of diet have a significant
reduction in Aβ plaque aggregation and higher cerebral metabolic rates (indicating increased
cortical brain function) and decreased risk of AD development (Pistollato et al., 2016). There are
also some herbs and teas that have neuroprotective properties (Pistollato et al., 2016).
Plant phenolics and iron
Another remedial approach is an increased intake of antioxidants including plant derived
foods that contain phenol groups including green tea, dates, virgin olive oil, and red wine. These
substances have been correlated with lower plaque and Tau aggregations as well as less cerebral
inflammation. Phytochemicals and other plant components such as tea phenolics have been
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known to hinder the proliferation of Clostridium difficile, and Clostridium perfringens (the
increased concentration of these types of bacteria has been known to cause a disease state of the
gut). Iron containing red meat is an oxidant and can worsen cerebral oxidation. Abnormally high
intake of iron containing red meat can result in the formation of fibrin fibers that cause red blood
cell to clot. These blood clots can then prevent oxygen from accessing the CNS. Therefore, low
amounts of red meat consumed could be a preventative measure for AD pathogenesis (Pistollato
et al., 2016).
Prebiotics and probiotics
In addition to prebiotics and various phenolics, a balanced intake of probiotics in foods
such as kefir and kambucha, or other foods that are rich in “good” bacteria (such as
Lactobacillus and Bifidobacterium) help maintain a healthy gut microbiome. For instance, the
implementation of probiotic and prebiotic regimens in the elderly have resulted in an increase in
Bifidobacterium and decrease in inflammatory cytokines including IL-5, IL-6, IL-1b, IL-8, and
TNF-a (Pistollato et al., 2016).
Fecal microbiota transplants
An interesting possible method to remedy a dysbiotic gut microbiome is fecal microbiota
transplants (FMT). FMT donations from healthy donors with a diverse gut microbiome are being
used in hospitals today to treat C. difficile infections (CDI) by reestablishing a diverse gut
microbiome (Austin et al., 2019). There are also promising studies that show that FMT in mice
can dramatically reduce the prevalence of Parkinson’s Disease (PD) (Yang et al., 2018). While
the effects of the microbiome and FMT in PD have been more thoroughly studied than in AD,
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these two neurodegenerative disease states have analogues mechanisms. With more testing it is
highly plausible that FMT could be used in a similar manner to treat AD.
Oral hygiene
Additionally, with regard to the oral microbiome, maintaining good oral hygiene could
decrease risk for AD. Good oral hygiene prevents the stratification of bacteria in the mouth that
provide anaerobic niches leading to increased populations of anaerobic bacteria. Specifically,
avoiding the overgrowth of anaerobic bacteria P. gingivalis has been shown to decrease the
buildup of Aβ plaque in the brain (Shoemark & Allen, 2014).

Conclusion

In conclusion, gut and oral microbiome does indeed play a role in the development of
AD. The healthiest microbiome has a more varied relative abundance of a diverse array of
bacteria. Deviation from a symbiotic state of bacterial abundance can have serious local and
systemic ramifications. The gut microbiome is established at a young age and should remain
relatively constant after the age of two. Microbes have an important role in systemic signaling
and digestion in the human body and are hugely beneficial to the host under homeostatic
conditions. Microbes can communicate with the brain through bacterial translocation or the
transfer of their metabolites and cytokines throughout the blood stream. This form of
communication is more prevalent when there is an increased permeability of membranes.
Additionally, microbes can communicate to the brain by stimulating the transmission of
neurotransmitters through the nervous system to the brain.
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Late onset AD can be brought about by genetic allelic expression of apoe4 and by
environmental factors such as dysbiosis of the microbiome. AD is characterized by an overactive
immune response caused by a buildup of Aβ plaque and Tau protein in the brain. Microbial
dysbiosis can contribute to the pathogenesis of AD. AD patients often have gut microbiome
dysbiosis caused by an increase in Gram-negative Bacteroides and a decrease in Firmicutes and
Bifidobacterium. Bacteroides induce the production of LPS that invoke cerebral inflammation
and Aβ aggregation. Firmicutes and Bifidobacterium help prevent membrane permeability.
Firmicutes specifically produce SCFA butyrate that helps nourish the epithelial membrane of the
gut. There is also an overall decrease in bacterial biodiversity in AD patients. The oral
microbiome is characterized by an increase in anaerobic bacteria such as P. gingivalis, producing
gingipain enzymes that buildup in exactly the same locations as Aβ plaque and Tau tangles.
The composition of the gut and oral microbiomes has changed over the course of human
history and within a single life span. The human microbiome is sensitive to a multitude of
environmental variables. Diet is one of the most prominent influences on the composition of the
microbiome. Non-Western or traditional diets characteristic of hunter-gatherer populations have
lower amounts of sugar and fat and higher amounts of fiber. Experiments show that these diet
types have a stabilizing effect on the gut microbiome with an increase in Bifidobacterium. We
see the opposite effect in those that consume a western type diet with more fats and sugars and
less fiber. This results in a decrease in Bifidobacterium and an increase in the Firmicutes and
Bacteroides ratio resulting in an overall decrease in bacterial diversity, and an increase in
membrane permeability and inflammation. AD was also shown to be comorbid with Diabetes 2,
both of which have a characteristically similar state of dysbiosis. Furthermore, the inhibition of
glucose metabolism as a result of diabetes may contribute to the pathogenesis of AD. Aging also
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contributes heavily to AD pathogenesis. There is a similar dysbiotic shift in older people that
resembles that of AD patients, specifically an increase in Gram-negative bacteria in the gut and
an increase of anaerobic bacteria in the mouth.
Finally, holistic methods of AD prevention are mainly based on the attempt to maintain a
stable, diverse microbiota. These methods include the following measures: moderate
consumption of probiotics, prebiotics, and plant derived phenolics. There should also be a
limited consumption of red meats. This generally reflects a Non-Western diet type. Research
shows that perhaps FMT could be used to reestablish a functional gut microbiome and lessen the
pathogenic causative agents and effects of AD. It is clear that there is more research to be done
regarding the mechanistic effect of the microbiome and neurodegenerative disorders such as AD,
as there are countless contributing factors in the equation. However, it is interesting to see a clear
correlation between two systems that were once thought to be entirely isolated. Hopefully,
further research will lead to a better understanding of this novel intrinsic ecosystem and perhaps
contribute to AD therapies or preventative measures.
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